Gritstone Oncology And Ebix On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Gritstone Oncology, Glory Star New Media Group Holdings Limited, and Canopy Growth.

Rank Financial Asset Price Change Updated (EST)
1 Gritstone Oncology (GRTS) 2.45 20.69% 2023-10-04 15:47:05
2 Glory Star New Media Group Holdings Limited (GSMGW) 0.01 9% 2023-10-04 16:23:06
3 Canopy Growth (CGC) 0.74 8.94% 2023-10-04 12:22:52
4 Eastside Distilling (EAST) 1.78 8.54% 2023-10-03 19:11:09
5 Whole Earth Brands (FREEW) 0.13 8.33% 2023-10-04 07:11:06
6 Aware, Inc. (AWRE) 1.48 6.47% 2023-10-04 12:10:56
7 GreenPower Motor Company (GP) 3.14 5.72% 2023-10-04 15:09:07
8 Xenetic Biosciences (XBIO) 4.41 5.5% 2023-10-04 12:17:35
9 Fusion Pharmaceuticals (FUSN) 3.39 5.28% 2023-10-04 09:15:07
10 Globalstar (GSAT) 1.33 5.16% 2023-10-04 13:00:57

The three biggest losers today are Ebix, Esports Entertainment Group, and Kosmos Energy.

Rank Financial Asset Price Change Updated (EST)
1 Ebix (EBIX) 6.07 -26.27% 2023-10-04 12:11:52
2 Esports Entertainment Group (GMBL) 0.10 -12.92% 2023-10-04 13:11:06
3 Kosmos Energy (KOS) 7.05 -8.44% 2023-10-04 12:56:28
4 eXp World Holdings (EXPI) 14.39 -8.34% 2023-10-03 23:48:07
5 TherapeuticsMD (TXMD) 2.65 -8.3% 2023-10-04 12:17:25
6 DZS (DZSI) 1.85 -7.04% 2023-10-03 19:10:06
7 TD Holdings (GLG) 0.13 -7.02% 2023-10-04 13:09:06
8 EHang Holdings Limited (EH) 16.99 -6.6% 2023-10-03 19:46:10
9 Enlivex Therapeutics Ltd. (ENLV) 1.48 -6.32% 2023-10-03 19:55:28
10 Novavax (NVAX) 7.19 -6.31% 2023-10-04 12:13:56

Winners today

1. Gritstone Oncology (GRTS) – 20.69%

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.

NASDAQ ended the session with Gritstone Oncology rising 20.69% to $2.45 on Wednesday, following the last session’s upward trend. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Gritstone Oncology has a trailing twelve months EPS of $-1.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.62%.

More news about Gritstone Oncology.

2. Glory Star New Media Group Holdings Limited (GSMGW) – 9%

Glory Star New Media Group Holdings Limited provides advertisement and content production services in China. The company also engages in the mobile and online advertising, digital media, and entertainment businesses. In addition, it offers CHEERS app, an e-commerce platform, which provides online store, live streaming, and online games, as well as online short videos, variety shows, and dramas. Glory Star New Media Group Holdings Limited was founded in 2016 and is headquartered in Beijing, China.

NASDAQ ended the session with Glory Star New Media Group Holdings Limited rising 9% to $0.01 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Glory Star New Media Group Holdings Limited has a trailing twelve months EPS of $0.54.

PE Ratio

Glory Star New Media Group Holdings Limited has a trailing twelve months price to earnings ratio of 0.02. Meaning, the purchaser of the share is investing $0.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.45%.

Yearly Top and Bottom Value

Glory Star New Media Group Holdings Limited’s stock is valued at $0.01 at 17:32 EST, below its 52-week high of $0.01 and way higher than its 52-week low of $0.01.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 154.58M for the twelve trailing months.

More news about Glory Star New Media Group Holdings Limited.

3. Canopy Growth (CGC) – 8.94%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth jumping 8.94% to $0.74 on Wednesday, after five sequential sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-1.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.

More news about Canopy Growth.

4. Eastside Distilling (EAST) – 8.54%

Eastside Distilling, Inc. manufactures, acquires, blends, bottles, imports, exports, markets, and sells various alcoholic beverages. The company provides rum under the brand name of Hue-Hue Coffee Rum; tequila under the Azuñia Tequila brand; vodka under the Portland Potato Vodka brand name; and whiskey under the Burnside Whiskey brand. It also offers gin and ready-to-drink products. The company sells its products on a wholesale basis to distributors in the United States. Eastside Distilling, Inc. was founded in 2008 and is headquartered in Portland, Oregon.

NASDAQ ended the session with Eastside Distilling rising 8.54% to $1.78 on Wednesday, after three successive sessions in a row of gains. NASDAQ rose 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Eastside Distilling has a trailing twelve months EPS of $-19.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -415.33%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 52.8% and 88.3%, respectively.

More news about Eastside Distilling.

5. Whole Earth Brands (FREEW) – 8.33%

NASDAQ ended the session with Whole Earth Brands jumping 8.33% to $0.13 on Wednesday while NASDAQ jumped 1.35% to $13,236.01.

Yearly Top and Bottom Value

Whole Earth Brands’s stock is valued at $0.13 at 17:32 EST, way under its 52-week high of $0.15 and way above its 52-week low of $0.07.

More news about Whole Earth Brands.

6. Aware, Inc. (AWRE) – 6.47%

Aware, Inc., a authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, Brazil, the United Kingdom, and internationally. The company offers biometric software solution, which includes Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification. It also provides BioSP, a service-oriented platform enables biometric system with advanced biometric data processing and management in a web services architecture; WebEnroll, a browser-based biometric enrollment and data management solution; and AwareID, an adaptive authentication platform provides biometric face and voice analysis, and document validation for cloud-based biometric application programming interfaces and turnkey services. In addition, the company offers biometrics applications, such as Nexa line, a biometric search and match SDKs including Nexa Fingerprint, Nexa Face, Nexa Iris, and Nexa Voice; and AwareXM, an interoperable fingerprint matching SDK that provides fingerprint minutiae extraction, template generation, and fingerprint authentication. Further, it sells imaging products used in medical and advanced imaging application; offers program management and software engineering services, and software maintenance services. The company sells its products, services, and solutions through systems integrators, direct, and original equipment manufacturers and value added resellers channel Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

NASDAQ ended the session with Aware, Inc. rising 6.47% to $1.48 on Wednesday, following the last session’s downward trend. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.86%.

Volatility

Aware, Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.90%, a negative 0.04%, and a positive 2.46%.

Aware, Inc.’s highest amplitude of average volatility was 2.90% (last week), 3.38% (last month), and 2.46% (last quarter).

More news about Aware, Inc..

7. GreenPower Motor Company (GP) – 5.72%

GreenPower Motor Company Inc. develops, manufactures, and distributes electric vehicles for commercial markets in the United States and Canada. It offers all-electric transit, school, and charter buses. The company is based in Vancouver, Canada.

NASDAQ ended the session with GreenPower Motor Company rising 5.72% to $3.14 on Wednesday, after three successive sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, GreenPower Motor Company has a trailing twelve months EPS of $-0.53.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.75%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 33.3% and 57.1%, respectively.

More news about GreenPower Motor Company.

8. Xenetic Biosciences (XBIO) – 5.5%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences jumping 5.5% to $4.41 on Wednesday while NASDAQ jumped 1.35% to $13,236.01.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-2.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.99%.

Moving Average

Xenetic Biosciences’s value is higher than its 50-day moving average of $4.31 and above its 200-day moving average of $4.18.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Xenetic Biosciences’s EBITDA is 5.81.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.90%, a negative 0.02%, and a positive 3.46%.

Xenetic Biosciences’s highest amplitude of average volatility was 8.90% (last week), 3.92% (last month), and 3.46% (last quarter).

More news about Xenetic Biosciences.

9. Fusion Pharmaceuticals (FUSN) – 5.28%

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is involved in the progressing of its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.

NASDAQ ended the session with Fusion Pharmaceuticals jumping 5.28% to $3.39 on Wednesday, following the last session’s upward trend. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Fusion Pharmaceuticals has a trailing twelve months EPS of $-2.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Yearly Top and Bottom Value

Fusion Pharmaceuticals’s stock is valued at $3.39 at 17:32 EST, way below its 52-week high of $5.63 and way above its 52-week low of $1.98.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 27.3% and 23.6%, respectively.

Volume

Today’s last reported volume for Fusion Pharmaceuticals is 91069 which is 31.16% above its average volume of 69429.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fusion Pharmaceuticals’s EBITDA is -6.8.

More news about Fusion Pharmaceuticals.

10. Globalstar (GSAT) – 5.16%

Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications. It also provides one-way or two-way communications and data transmissions using mobile devices, including the SPOT family of products, such as SPOT X, SPOT Gen4, and SPOT Trace that transmit messages and the location of the device; commercial Internet of Things transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets; small satellite transmitter modules, such as the STX-3, ST-150 and ST100, and chips that enable an integrator's products to access company's network; and engineering and other communication services using MSS and terrestrial spectrum licenses, as well as undertakes installation of gateways and antennas. The company distributes its products through retailers, sales force, and e-commerce website. Globalstar, Inc. serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. The company was founded in 1993 and is headquartered in Covington, Louisiana.

NYSE ended the session with Globalstar rising 5.16% to $1.33 on Wednesday, after two consecutive sessions in a row of gains. NYSE rose 0.18% to $15,070.91, after three successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Globalstar has a trailing twelve months EPS of $-0.11.

Volume

Today’s last reported volume for Globalstar is 4600170 which is 9.7% below its average volume of 5094560.

Sales Growth

Globalstar’s sales growth is 42.8% for the present quarter and 31.6% for the next.

More news about Globalstar.

Losers Today

1. Ebix (EBIX) – -26.27%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix falling 26.27% to $6.07 on Wednesday while NASDAQ jumped 1.35% to $13,236.01.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $1.09.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 5.57. Meaning, the purchaser of the share is investing $5.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 52.8%, now sitting on 874.3M for the twelve trailing months.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 1, 2022, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 3.04%.

Volume

Today’s last reported volume for Ebix is 3266720 which is 275.3% above its average volume of 870410.

More news about Ebix.

2. Esports Entertainment Group (GMBL) – -12.92%

Esports Entertainment Group, Inc. operates as an online gambling company in Canada. The company offers esports entertainment, esports wagering, and iGaming and traditional sports betting services, as well as professional and amateur esports events. It also operates vie.gg, an online esports wagering website. The company was formerly known as VGambling, Inc. and changed its name to Esports Entertainment Group, Inc. in May 2017. Esports Entertainment Group, Inc. was incorporated in 2008 and is based in Birkirkara, Malta.

NASDAQ ended the session with Esports Entertainment Group sliding 12.92% to $0.10 on Wednesday, following the last session’s upward trend. NASDAQ rose 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Esports Entertainment Group has a trailing twelve months EPS of $17.09.

PE Ratio

Esports Entertainment Group has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing $0.01 for every dollar of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth declined by 73.4%, now sitting on 31.9M for the twelve trailing months.

Sales Growth

Esports Entertainment Group’s sales growth is negative 74.6% for the present quarter and 16.4% for the next.

Yearly Top and Bottom Value

Esports Entertainment Group’s stock is valued at $0.10 at 17:32 EST, way below its 52-week high of $23.80 and way above its 52-week low of $0.08.

More news about Esports Entertainment Group.

3. Kosmos Energy (KOS) – -8.44%

Kosmos Energy Ltd. engages in the exploration and production of oil and gas properties along the Atlantic Margins in the United States. The company's primary assets include production projects located in offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as a gas projects located in offshore Mauritania and Senegal. It also undertakes a proven basin exploration program in Equatorial Guinea and the U.S. Gulf of Mexico. Kosmos Energy Ltd. was founded in 2003 and is headquartered in Dallas, Texas.

NYSE ended the session with Kosmos Energy falling 8.44% to $7.05 on Wednesday, following the last session’s upward trend. NYSE rose 0.18% to $15,070.91, after three consecutive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Kosmos Energy has a trailing twelve months EPS of $0.45.

PE Ratio

Kosmos Energy has a trailing twelve months price to earnings ratio of 15.67. Meaning, the purchaser of the share is investing $15.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.41%.

Sales Growth

Kosmos Energy’s sales growth is 3.3% for the ongoing quarter and 0.3% for the next.

Volume

Today’s last reported volume for Kosmos Energy is 2668520 which is 44.75% below its average volume of 4830660.

Moving Average

Kosmos Energy’s value is under its 50-day moving average of $7.28 and higher than its 200-day moving average of $6.91.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kosmos Energy’s EBITDA is 28.52.

More news about Kosmos Energy.

4. eXp World Holdings (EXPI) – -8.34%

eXp World Holdings, Inc. provides cloud-based real estate brokerage services for residential homeowners and homebuyers. The company facilitates buyers to search real-time property listings and sellers to list their properties through its various platforms; and provides buyers and sellers with access to a network of professionals, consumer-centric agents, and brokers. It is also involved in building 3D virtual worlds for work, education, and events; and focused on agent website and consumer real estate portal technology. In addition, the company operates SUCCESS print magazine, SUCCESS.com portal, SUCCESS newsletters, podcasts, digital training courses, and affiliated social media accounts across platforms. Further, it provides marketing, training, and other support services to its brokers and agents through proprietary technology enabled services, as well as technology and support services contracted to third parties. The company operates in the United States, Canada, the United Kingdom, Australia, South Africa, India, Portugal, France, Mexico, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, and internationally. The company was formerly known as eXp Realty International Corporation and changed its name to eXp World Holdings, Inc. in May 2016. eXp World Holdings, Inc. was incorporated in 2008 and is based in Bellingham, Washington.

NASDAQ ended the session with eXp World Holdings sliding 8.34% to $14.39 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, eXp World Holdings has a trailing twelve months EPS of $0.05.

PE Ratio

eXp World Holdings has a trailing twelve months price to earnings ratio of 287.8. Meaning, the purchaser of the share is investing $287.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.14%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

eXp World Holdings’s EBITDA is 215.69.

Sales Growth

eXp World Holdings’s sales growth is negative 5.1% for the ongoing quarter and 7.1% for the next.

Yearly Top and Bottom Value

eXp World Holdings’s stock is valued at $14.39 at 17:32 EST, way under its 52-week high of $25.39 and way above its 52-week low of $9.96.

Moving Average

eXp World Holdings’s worth is way below its 50-day moving average of $20.02 and way under its 200-day moving average of $16.04.

More news about eXp World Holdings.

5. TherapeuticsMD (TXMD) – -8.3%

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with TherapeuticsMD sliding 8.3% to $2.65 on Wednesday, after two consecutive sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, TherapeuticsMD has a trailing twelve months EPS of $3.29.

PE Ratio

TherapeuticsMD has a trailing twelve months price to earnings ratio of 0.81. Meaning, the purchaser of the share is investing $0.81 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1134.2%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

TherapeuticsMD’s EBITDA is -15.58.

More news about TherapeuticsMD.

6. DZS (DZSI) – -7.04%

DZS Inc. provides network access solutions and communications platforms for service provider and enterprise networks in the Americas, Europe, the Middle East, Africa, and Asia. It offers mobile transport products, including standard Ethernet/IP or multiprotocol label switching interfaces and interoperate to mobile operators that enables them to upgrade their mobile fronthaul/backhaul systems and migrate to 5G and beyond; broadband access products, which consists of switching and routing products to carriers and service providers to connect residential and business customers; and connected premises products, comprising of indoor/outdoor optical network terminal gateways. The company also provides software and services, which consists of software defined networking orchestration solutions, network function virtualization, and professional and technical support services. It has a strategic partnership with Quanta Cloud Technology; and Plume Design, Inc. The company was formerly known as DASAN Zhone Solutions, Inc. and changed its name to DZS Inc. in August 2020. The company was founded in 1996 and is based in Plano, Texas.

NASDAQ ended the session with DZS falling 7.04% to $1.85 on Wednesday, after four sequential sessions in a row of losses. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, DZS has a trailing twelve months EPS of $-1.69.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.81%.

Moving Average

DZS’s value is way below its 50-day moving average of $2.58 and way below its 200-day moving average of $6.89.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.9%, now sitting on 389.46M for the twelve trailing months.

More news about DZS.

7. TD Holdings (GLG) – -7.02%

TD Holdings, Inc. focuses on the new commodities trading business. The company was formerly known as Bat Group, Inc. and changed its name to TD Holdings, Inc. in March 2020. TD Holdings, Inc. is based in Beijing, the People's Republic of China.

NASDAQ ended the session with TD Holdings sliding 7.02% to $0.13 on Wednesday, after five sequential sessions in a row of losses. NASDAQ rose 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, TD Holdings has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.09%.

Volume

Today’s last reported volume for TD Holdings is 2924780 which is 50.43% below its average volume of 5900870.

Moving Average

TD Holdings’s value is way under its 50-day moving average of $0.36 and way below its 200-day moving average of $0.76.

Earnings Before Interest, Taxes, Depreciation, and Amortization

TD Holdings’s EBITDA is -69.67.

Revenue Growth

Year-on-year quarterly revenue growth declined by 35.7%, now sitting on 124.08M for the twelve trailing months.

More news about TD Holdings.

8. EHang Holdings Limited (EH) – -6.6%

EHang Holdings Limited operates as an autonomous aerial vehicle (AAV) technology platform company in the People's Republic of China, North America, East Asia, Europe, West Asia, and internationally. It designs, develops, manufactures, sells, and operates AAVs, as well as their supporting systems and infrastructure for a range of industries and applications, including passenger transportation, logistics, smart city management, and aerial media solutions. EHang Holdings Limited has a strategic partnership with Shenzhen Expressway Operation Development Company Limited. The company was incorporated in 2014 and is headquartered in Guangzhou, the People's Republic of China.

NASDAQ ended the session with EHang Holdings Limited sliding 6.6% to $16.99 on Wednesday, following the last session’s downward trend. NASDAQ rose 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, EHang Holdings Limited has a trailing twelve months EPS of $-0.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -170.28%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

EHang Holdings Limited’s EBITDA is -12.56.

Sales Growth

EHang Holdings Limited’s sales growth for the next quarter is 182%.

Moving Average

EHang Holdings Limited’s worth is under its 50-day moving average of $18.68 and way above its 200-day moving average of $13.52.

Volume

Today’s last reported volume for EHang Holdings Limited is 535040 which is 39.2% below its average volume of 880065.

More news about EHang Holdings Limited.

9. Enlivex Therapeutics Ltd. (ENLV) – -6.32%

Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel.

NASDAQ ended the session with Enlivex Therapeutics Ltd. falling 6.32% to $1.48 on Wednesday, after two sequential sessions in a row of losses. NASDAQ rose 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, Enlivex Therapeutics Ltd. has a trailing twelve months EPS of $-1.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.74%.

Volume

Today’s last reported volume for Enlivex Therapeutics Ltd. is 15704 which is 40.85% below its average volume of 26553.

Yearly Top and Bottom Value

Enlivex Therapeutics Ltd.’s stock is valued at $1.48 at 17:32 EST, way below its 52-week high of $4.92 and above its 52-week low of $1.36.

Moving Average

Enlivex Therapeutics Ltd.’s worth is way under its 50-day moving average of $2.26 and way under its 200-day moving average of $3.08.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Enlivex Therapeutics Ltd.’s EBITDA is -2.72.

More news about Enlivex Therapeutics Ltd..

10. Novavax (NVAX) – -6.31%

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax falling 6.31% to $7.19 on Wednesday, following the last session’s upward trend. NASDAQ jumped 1.35% to $13,236.01, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Novavax (nvax) up 8% on FDA nod for updated covid booster jabNovavax (NVAX Quick QuoteNVAX – Free Report) announced that the FDA has granted emergency use authorization (EUA) to Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula), an updated version of its protein-based COVID-19 vaccine, in individuals aged 12 years and older., Shares of Novavax have lost 25.4% year to date compared with the industry’s 17.6% decline.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-7.22.

More news about Novavax.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *